Roles of retinoids and their nuclear receptors in the development and prevention of upper aerodigestive tract cancers

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 4, 1997, Pages 985-988

  Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemoprevention; Lung cancer; Nuclear receptors; Oral cancer; Retinoids

Indexed keywords

CELL NUCLEUS RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; RETINOL; TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; CELL GROWTH; CHEMOPROPHYLAXIS; CONFERENCE PAPER; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; LUNG CARCINOGENESIS; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND CANCER; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030770439     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s4985     Document Type: Conference Paper

References (52)

1. Wingo PA, Tong T, Bolden S. Cancer Statistics, 1995. CA Cancer J Clin 45:8-30 (1995).
2. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 328:184-194 (1993).
3. Shopland DR, Eyre HJ, Pechacek TF. Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 83:1142-1148 (1991).
4. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 85:457-464 (1993).
5. Lubin JH, Blot WJ. Lung cancer and smoking cessation: patterns of risk. J Natl Cancer Inst 85:422-423 (1993).
6. Slaughter DP, Southwick HW, Smejkel W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 6:963-968 (1953).
7. Strong MS, Incze J, Vaughan CW. Field cancerization in the aerodigestive tract - its etiology, manifestations, and significance. J Otolaryngol 12:1-6 (1984).
8. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 12:851-873 (1994).
9. Sporn MB, Newton DL. Chemoprevention of cancer with retinoids. Fed Proc 38:2528-2534 (1979).
10. Hong WK, Itri LM. Retinoids and human cancer. In: The Retinoids (Sporn MB, Roberts AB, Goodman DS, eds). New York:Raven Press, 1994;597-658.
11. Hong W, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C et al. 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501-1505 (1986).
12. Hong WK, Lippman SM, Itri LM, Karp DD, Lee, JS, Byers RM, Schantz SS, Kramer AM, Lotan R, Peters LL et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323:795-801 (1990).
13. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GJ, Goepfert H, Hong WK. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 328: 15-20 (1993).
14. Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 62:753-777 (1925).
15. Auerbach O, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med 300:381-386 (1979).
16. Wolbach SB. Effects of vitamin A deficiency and hypervitaminosis in animals. In: The Vitamins, Vol 1 (Sebrell WH, Harris RS, eds). New York:Academic Press, 1956;106-137.
17. Moon RC, Mehta RG. Retinoid inhibition of experimental carcinogenesis. In: Chemistry and Biology of Synthetic Retinoids (Dawson MI, Okamura WH, eds). Boca Raton, FL:CRC Press, 1990;501-518.
18. Shklar G, Schwartz J, Grau D, Trickler DP, Wallace KD. Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. Oral Surg 50:45-52 (1980).
19. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Pirket P, Rosementz N, Clerici M, Soresi E, Valente M et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 11:1216-1222 (1993).
20. Lotan R, Lotan D, Sacks PG, Hong WK. Distinct effects of retinoic acid on the in vitro growth and cell surface glycoconjugates of two human head and neck squamous celt carcinomas. Int J Cancer 40:224-229 (1987).
21. Sacks PG, Oke V, Amos B, Vasey T, Lotan R. Modulation of growth, differentiation, and glycoprotein synthesis by β-all-trans retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int J Cancer 45:926-933 (1989).
22. Jetten AM, Kim JS, Sacks PG, Rearick JI, Lotan D, Hong WK, Lotan R. Suppression of growth and squamous cell differentiation markers in cultured human head and neck squamous carcinoma cells by β-all trans-retinoic acid. Int J Cancer 45:195-202 (1990).
23. Lotan R, Lotan D, Sacks PG. Inhibition of tumor cell growth by retinoids. Methods Enzymol 190:100-110 (1990).
24. Poddar S, Hong K, Thacher S, Lotan R. Suppression of type I transglutaminase, involucrin and keratin K1 in cultured human head and neck squamous carcinoma 1483 cells by retinoic acid. Int J Cancer 48:239-247 (1991).
25. Kim JS, Steck PA, Gallick GE, Lee JS, Blick M, Hong WK, Lotan R. Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells. J Natl Cancer Inst Monog 13:101-110 (1992).
26. Zou C, Clifford JL, Xu X-C, Sack, PG, Chambon P, Hong WK, Lotan R. Modulation by retinoic acid of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous carcinoma cell lines. Cancer Res 54:5479-5487 (1994).
27. Oridate N, Lotan D, Lotan R. Reconstituted basement membrane (Matrigel): a useful semisolid medium for anchorage-independent growth of tumor cells. In Vitro Cell Develop Biol 32:192-193 (1996).
28. Lotan R. Squamous cell differentiation markers in normal, premalignant, and malignant epithelium: effects of retinoids. J Cell Biochem (Suppl 17F):167-174 (1993).
29. Gudas LJ, Sporn MB, Roberts AB. Cellular biology and biochemistry of the retinoids. In: The Retinoids (Sporn MB, Roberts AB, DS Goodman, eds). New York:Raven Press, 1994;443-520.
30. Lotan R, Clifford JL. Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells. Biomed Pharmacother 45:145-156 (1990).
31. DeLuca LM. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. Fed Am Soc Exp Biol J 5:2924-2933 (1991).
32. Chambon P. The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 5:115-125 (1994).
33. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: The Retinoids (Sporn MB, Roberts AB, Goodman DS, eds). New York:Raven Press, 1994;319-349.
34. Pfahl M. Vertebrate receptors: molecular biology, dimerization and response elements. Sem Cell Biol 5:95-103 (1994).
35. Lotan R, Xu X-C, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK. Suppression of retinoic acid receptor β in premalignant oral lesions and its upregulation by isotretinoin. N Engl J Med 332:1405-1410 (1995).
36. Zelent A, Mendelsohn C, Kastner P, Krust A, Garnier JM, Ruffenach, F Leroy P, Chambon P. Differentially expressed isoforms of the mouse retinoic acid receptor β are generated by usage of two promoters and alternative splicing. Eur Mol Biol Organ J 10:71-81 (1991).
37. Clifford JL, Petkovich M, Chambon P, Lotan R. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells. Mol Endocrinol 4:1546-1555 (1990).
38. Oridate N, Zou CP, Mitchell MF, Hong WK, Lotan R. Activation by retinoic acid of native retinoic acid receptor β2 promoter is suppressed in human oral squamous cell carcinoma SqCC/Y1 cells. Mol Cell Diff 2:413-431 (1994).
39. Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG. High frequency of retinoic acid receptor beta abnormalities in human lung cancer. Oncogene 6:1859-1868 (1991).
40. Houle B, Leduc F, Bradley WE. Implication of RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer 3:358-366 (1991).
41. Nervi C, Vollberg TM, George MD, Chambon P, Jetten AM. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp Cell Res 195:163-170 (1991).
42. Geradts J, Chen J-Y, Russell EK, Yankaskas JR, Nieves L, Minna JD. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Diff 4:799-809 (1993).
43. Houle B, Rochette-Egly C, Bradley WE. Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 90:985-989 (1993).
44. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 51:3972-3981 (1991).
45. Bartsch D, Boye B, Baust C, zur Hausen H, Schwarz E. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrid cells. Eur Mol Biol Organ J 11:2283-2291 (1992).
46. Zhang X-K, Liu Y, Lee M-O, Pfahl M. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res 54:5663-5669 (1994).
47. Xu X-C, Clifford, JL, Hong WK, Lotan R. Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry. Diag Mol Pathol 3:122-131 (1994).
48. Xu X-C, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Differential expression of nuclear retinoic acid: receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54:3580-3587 (1994).
49. Sozzi G, Xu X-C, Ro J, Lee JS, Pastorino U, Pilotti S, Kurie J, Hong WK, Lotan R. Selective suppression of retinoic acid receptor β (RARβ) expression in non-small cell lung cancers (NSCLC). Proc Am Soc Clin Oncol (1995).
50. Verma AK, Shoemaker A, Simsiman R, Denning M, Zachman RD. Expression of retinoic acid nuclear receptors and tissue transglutaminase is altered in various tissues of rats fed a vitamin A-deficient diet. J Nutr 122:2144-2152 (1992).
51. Kato S, Mano HM, Kumazawa T, Yoshizawa Y, Kojima R, Masushige S. Effect of retinoid status on alpha, beta and gamma retinoic acid receptor mRNA levels in various rat tissues. Biochem J 286:755-760 (1992).
52. Xu X-C, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R. Anti-retinoic acid antibody binding to human premalignant oral lesions is lower than to normal tissue, is increased after 13-cis-retinoic acid treatment in vivo, and is related to retinoic acid receptor beta expression. Cancer Res 55:5507-5511 (1995).